跳至主要内容
临床试验/IRCT20210925052566N1
IRCT20210925052566N1尚未招募1 期

Transplantation of allogenic mesenchymal stem cells (MSCs) derived from placenta and adipose tissue for the treatment of type 1 diabetes mellitus (T1DM): a clinical trial, phase 1 and 2.

Endocrinology and Metabolism Research Institute0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • All adults (= 18 year) with T1DM which diagnosis less than 1 year from the onset of diabetes
  • Have at least one T1DM related autoantibody

排除标准

  • Inability to fill informed consent
  • Pregnancy in women
  • Having any chronic complication of diabetes including nephropathy, retinopathy and vascular complications
  • Having a serious infection or have a positive test for hepatitis B, hepatitis C or HIV
  • Having other chronic comorbidities such as psychological, cardiovascular, renal, pulmonary, liver, hematologic and other serious autoimmune diseases (except T1DM or Hashimoto's disease)
  • History of cancer
  • History of diabetic ketoacidosis

研究者

发起方
Endocrinology and Metabolism Research Institute

相似试验